Articles tagged with Antibiotics
The study found that antibiotics and synthetic hormones can increase antibiotic resistance and disrupt endocrine functions. Researchers identified key metabolites from commonly prescribed medications and hormone replacement therapy, highlighting the need for optimized wastewater treatment processes to remove these compounds.
A recent Johns Hopkins Medicine study found that a single dose of azithromycin significantly reduces the risk of trichiasis recurring for up to one year after lid surgery. The researchers compared azithromycin to six weeks of topical tetracycline treatment and found that azithromycin resulted in one-third fewer recurrences.
Researchers found PDT to be highly effective against drug-resistant bacteria and fungus, including S. mutans and Candida species, with minimal doses of light required to kill nearly all organisms.
Scientists successfully synthesized nisin, a peptide antibiotic, in a test tube using just two enzymes. The compound's unique structure and properties make it a potential candidate for developing new antibiotics with reduced resistance.
Researchers at the University of Michigan have developed a novel method to weaken Gram-negative bacteria, including E. coli, making them susceptible to existing antibiotics. The approach, which involves genetic modification, has shown promising results in reducing antibiotic doses needed to kill the bacteria.
A study found that a single mass antibiotic treatment does not prevent the return of eye infections in communities with high disease prevalence. Infection rates rose again after 2 years, highlighting the need for repeated treatments or other measures to eliminate infection.
A recent study indicates a significant increase in antibiotic-resistant community-acquired Staphylococcus aureus (MRSA) infections, affecting urban populations in the Atlanta area. The study reveals that 72% of community-onset skin and soft tissue infections are now due to MRSA USA300 strain.
The study found that timely antibiotic treatment was key to patients' survival, with a mortality rate of nearly 80% when treatment was delayed beyond six days. Anthrax progression to its advanced stage often leads to certain death, even with modern care.
Researchers successfully synthesized a novel vancomycin analogue with enhanced binding ability, showing promise in treating vancomycin-resistant infections. The new compound could potentially lead to the development of more effective antibiotics against these resistant strains.
A study led by Dr. Antonio Anzueto found that the newer medication moxifloxacin HCI is more effective at treating community-acquired pneumonia (CAP) in elderly patients, with a recovery rate of 97.9%, compared to 90% for the standard medication levofloxacin. The study also assessed cardiac safety and found both treatments to be safe.
Researchers genetically engineered E. coli to lack its outer protective layer, making it more vulnerable to antibiotics. Synthetic versions of natural substrates for gram-positive bacteria's membrane formation are also being developed, potentially leading to new antibiotic designs.
Researchers report three cases of severe liver failure and hepatitis linked to telithromycin, a newly approved antibiotic. The study highlights the potential risk of idiosyncratic drug reactions at one medical center.
Researchers screened 480 strains of soil bacteria for resistance to 21 antibiotics and found that all were multi-drug resistant. The study suggests that studying resistance in the soil can help predict future clinical problems and guide the development of new therapies.
Long-term antibiotic medication does not prevent recurrent myocardial infarcts in patients without periodontitis. Patients with periodontitis are more likely to experience cardiovascular events, especially under the age of 65.
A study found that current use of proton pump inhibitors was associated with nearly 3 times the rate of CDAD; use of H2-receptor antagonists was associated with twice the rate of CDAD. The rates and severity of nosocomial CDAD are increasing, posing a significant public health concern.
A recent study published at the American College of Gastroenterology's annual meeting found that targeted antibiotics, specifically rifaximin, resulted in a significant and long-lasting improvement in IBS symptoms. Patients who received the antibiotic experienced a 37% overall improvement in their symptoms, compared to 23% on placebo.
Scientists have captured high-resolution snapshots of the bacterial ribosome, allowing them to build more detailed models and gain insights into how specific antibiotics work. The new data reveals the ribosome's structure and function during protein manufacturing, including its ability to withstand stress and neutralize negative charge.
Researchers have discovered additional sites on ribosomes that could be targeted by antibiotics to combat bacterial resistance. The study provides new potential targets for pharmaceutical companies to create novel antibiotics, keeping pace with the evolving threat of antibiotic resistance.
Researchers at Harvard Medical School have identified a custom small molecule inhibitor that can prevent cholera bacteria from setting up an infection. The approach uses virulence protein expression and has potential to be widely applicable against other important pathogens.
A team of researchers has isolated a new defensin, plectasin, from fungi that is highly effective against drug-resistant bacteria. Plectasin targets specific strains of Streptococcus pneumoniae and Streptococcus pyogenes, including those resistant to conventional antibiotics.
Sheila West and colleagues found that yearly mass treatment significantly reduced the prevalence of chlamydia trachomatis infection in a Tanzanian community. However, infection re-emerged after 1-year, highlighting the need for sustained antibiotic coverage.
A study suggests a possible link between amoxicillin use in early infancy and an increased risk of dental fluorosis, a condition caused by excessive fluoride exposure. The research found that the duration of amoxicillin use was related to the severity of fluorosis on permanent teeth.
A review by Stephen Gillespie and Philippe Gay finds no evidence of antibiotic resistance from GM crops being transferred to bacteria, which would be dwarfed by the impact of human antibiotics use. The authors conclude that while it's possible for transfer to occur, its contribution to antibiotic resistance is low.
Researchers at Jefferson Medical College have developed a bonding method to create a permanent chemical bond between antibiotics and titanium, allowing it to kill bacteria and prevent infection. This technique has the potential to combat implant-related infections by creating an antibiotic surface that prevents infection from starting.
Researchers report a disturbing convergence of drug-resistant bacteria and virulent new strains of Staph. aureus, leading to severe illness and death in previously healthy children. The study highlights the need for better treatments and a vaccine to combat this growing threat.
Researchers discovered four mutations that increase the efficiency of a bacterial enzyme rendering penicillin and cephalosporin antibiotics useless. The mutations influenced the enzyme's active site, allowing it to survive on a drug dose 64 times higher than the original enzyme.
A study found that patients with acne treated with long-term antibiotics were more likely to develop upper respiratory tract infections (URTIs). The researchers identified individuals diagnosed with acne between 1987 and 2002, comparing the incidence of URTIs in those who received antibiotic treatment versus those who did not.
Researchers discovered that low doses of azithromycin can halt and reverse lung function decline in the majority of lung transplant patients with BOS, offering a new hope for treatment.
A new single-dose ciprofloxacin treatment has been shown to be effective in treating childhood cholera, with 60% of cases cured within 48 hours. However, the new treatment is less effective at eradicating the cholera bacteria from stool compared to a 12-dose course of erythromycin.
Researchers in France tested two intervention methods to reduce antibiotic use in kindergarteners, resulting in a 15% decline in antibiotic use. The study found that reduced antibiotic pressure allowed drug-susceptible bacteria to re-establish themselves as dominant colonizers of the respiratory tract.
Bon Appétit is recognized for its 'Circle of Responsibility' program, incorporating environmentally responsible and sustainable practices such as farm-to-fork sourcing, organic food options, and fair trade choices. The company's commitment to sustainability promotes the health of people and the environment.
A new study found that patient-delivered partner treatment reduces STD recurrence and transmission. The method involves giving patients antibiotics to offer to their partners, resulting in higher referral rates and reduced unprotected sex.
A new study shows that taking antibiotics within two months increases the likelihood of developing resistant bacteria. GPs are responsible for most antibiotic prescriptions in the UK, but may underestimate the individual risk.
A panel of experts judged the relevance of 15 quality indicators, which combined evidence and expert opinion to assess care aspects. The final list included recommendations such as timely initiation of antibiotic therapy and switching to focused antibiotics.
Antibiotic-resistant bacteria can be transmitted from animals to humans through contaminated food and handling practices. The European Union ban on agricultural antibiotics has led to a decline in resistant bacteria, suggesting that transmission from agriculture can have a greater impact on human populations than hospital transmission.
A recent study found that outpatient care in the US has made modest improvements in some areas, but still lags behind evidence-based recommendations. The research highlights significant disparities in care, particularly for racial and ethnic minority groups.
Researchers found that doxycyclin effectively killed micro-filariae and adult Wuchereria worms, reducing symptoms of elephantiasis. The antibiotic's low side-effect profile and affordability make it a promising treatment option for this disease.
A recent review confirms a moderate effect of antibiotics on illness course in acute lower respiratory tract infection. However, the debate continues about the role of antibiotics due to limited evidence. The study found that adopting delayed or no antibiotic strategies reduces both antibiotic use and belief in their effectiveness.
A randomized trial found that antibiotic treatment does not significantly improve cure rates in children with conjunctivitis. The researchers suggest parents treat children themselves without medical consultation unless symptoms persist or worsen.
A recent study found that an 8-week course of doxycycline effectively eliminated adult Wuchereria bancrofti worms, a key cause of elephantiasis. The treatment also reduced larval offspring populations, suggesting a promising approach for mass treatment.
A new study suggests that minor surgery plus antibiotics can prevent foot-bone infections and amputations. Patients with diabetes are at high risk, especially those with poor circulation and kidney problems.
A recent study found that a 'watch and wait' approach to treating kids' ear infections could significantly reduce the overuse of antibiotics. The study surveyed over 2,000 parents in Massachusetts communities, revealing mixed attitudes towards this treatment method.
A study by the American Thoracic Society found that measuring hormone levels can reduce antibiotic use in pneumonia patients. The study showed that patients with low procalcitonin levels were not given antibiotics and recovered similarly to those who received a full course of antibiotics.
Researchers found that rifaximin significantly improved disease activity in patients with Crohn's disease. The analysis of 8 patients showed a mean decrease in Harvey Bradshaw index of 7.1, indicating potential effectiveness as a treatment.
Researchers at Scripps Institute find a protein called LexA promotes mutations in bacteria, enabling them to evolve resistance to antibiotics. By inhibiting this protein, the bacteria's ability to evolve can be halted, potentially prolonging the potency of existing antibiotics.
A clinical trial found rifaximin effective in preventing travelers' diarrhea, with only 14.74% of participants experiencing symptoms after two weeks of daily dosing. The antibiotic lacks side effects and does not stimulate resistance in bacteria, making it a promising preventive measure.
Researchers found rifaximin significantly reduces mild diarrhea in travelers, while updated guidelines advise against hormone replacement therapy (HT) for postmenopausal women after hysterectomy. A study also discovered that slightly elevated blood sugar levels do not increase the risk of new heart attacks in women with established cor...
Researchers have discovered the structure of a membrane transporter protein used by bacteria and human cancer cells to evade drugs. This finding could lead to improved cancer therapy and more effective treatments for antibiotic-resistant infections. The protein, MsbA, plays a crucial role in bacterial cell growth and is now being studi...
Two studies document a significant rise in superbugs, including methicillin-resistant Staphylococcus aureus (MRSA), affecting people worldwide. The prevalence of MRSA has more than doubled, with 76% of community-acquired isolates being resistant to antibiotics.
Researchers propose that antibiotic-mediated DNA damage triggers a bacterial repair mechanism, increasing the likelihood of mutations leading to antibiotic resistance. Blocking this pathway could provide a promising strategy for controlling the spread of superbugs.
Researchers at Yale University have identified a key mechanism behind antibiotic resistance in bacteria. By analyzing the structural changes caused by a single nucleotide mutation, they found that this alteration reduces the ability of antibiotics to bind to ribosomes, allowing resistant bacteria to rapidly cause infections.
Scientists have made significant progress in understanding how bacteria develop resistance to antibiotics, including macrolides and lincosamides. The study revealed new details about the structural basis of drug resistance and identified potential targets for developing new hybrid antibiotics.
A recent US study found no benefit from treating C. pneumoniae bacteria with an antibiotic in reducing the risk of heart attack or improving overall cardiac outcomes. The Azithromycin coronary events study (ACES) assigned over 4,000 participants to receive either antibiotics or a placebo for one year.
A new study found that antibiotic treatment with azithromycin did not reduce the risk of heart attacks, unstable angina, or other cardiac events. The study enrolled over 4,000 participants and followed them for nearly four years, with no significant difference in outcomes between those receiving antibiotics and placebo.
Researchers found that combination therapy with antibiotics and vaccination is the best strategy for preventing death and disease, while also being the least costly option. The study suggests that widespread pre-attack vaccination is not particularly effective due to high costs, emphasizing the need for rapid distribution systems.
Researchers have found that a key clone of community-acquired MRSA has evolved from the 1950s pandemic-causing strain, developing resistance to meticillin antibiotics. The highly-virulent toxin Panton-Valentine leucocidin is shared by both strains, posing a serious public health challenge.
A study suggests that community acquired MRSA has evolved from a 1950s pandemic-causing strain, developing resistance to treatment by powerful antibiotics. The new strain shares the same highly-virulent toxin and poses a serious public health challenge.
Conventional poultry producers like Tyson and Perdue have higher rates of fluoroquinolone-resistant Campylobacter contamination than completely antibiotic-free brands like Eberly and Bell & Evans. The study's findings suggest a long-term threat to public health from using antibiotics in poultry production.
Max Planck scientists have developed a novel therapeutic strategy against anthrax using defensins. These molecules can neutralize the lethal toxin of anthrax bacilli, preventing its deadly effect and protecting against fatal consequences.
Kao's research uses DNA microarrays to measure gene expression and identify a mutation that increases the production of erythromycin by five days. By recreating this mutation, she aims to develop new antibiotic-producing bacteria, revolutionizing the field of antibiotic synthesis.